Splitomicin
Kurzübersicht für Splitomicin (ABIN7233294)
Applikation
Chemical Name
-
-
Verwendungszweck
- SIRT1 inhibitor
-
Produktmerkmale
- Initially shown to inhibit Sir2p (the yeast Sirt1 homolog) and create a conditional phenocopy of a sir2 deletion mutant in S. cerevisiae. Cells grown in the presence of the drug have silencing defects at telomeres, silent mating-type loci and the ribosomal DNA. Inhibits all class III HDACs (sirtuins) and alleviates gene silencing in Fragile X mental retardation syndrome. Reverses ischemic preconditioning-induced cardioprotection in a mouse model.
-
Reinheit
- >98 %
-
Formel
- C13H10O2
-
Löslichkeit
- Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Powder
-
Lagerung
- RT
-
-
-
Hintergrund
- Splitomycin,Epigenetics,Protein deacetylase,Ischemia,Heart disease,Posttranslational modification,Chromatin
-
Molekulargewicht
- 198.22
-
CAS-Nummer
- 5690-03-9
-
-